South Korea expands vaccination areas to combat FMD
South Korea on Monday decided to expand areas where vaccination will be administered in the face of the country's severest outbreak of foot-and-mouth disease (FMD), the government said.
Page 20 of articles about vaccine
European Union - Commission supplies Foot and Mouth Disease vaccine to Zambia
The European Commission has sent a consignment of Foot and Mouth Disease (FMD) vaccine to Zambia in order to help the African nation's efforts in fighting an outbreak of the disease in the northern part of the country. The consignment consists of 80,000 doses of FMD vaccine.
China - PCV vaccine developed in Henan
A vaccine against porcine circovirus (PCV) has been successfully developed in Henan Province and granted the National Registration Certificate for New Veterinary Drug and the production approval document number as well as the approval to be marketed as a national-level new veterinary drug of the second category from the Ministry of Agriculture (MOA).
Intervet/Schering-Plough Animal Health expands veterinary vaccine manufacturing facility at biosciences center Boxmeer
Intervet/Schering-Plough Animal Health announced that it has opened a specialized filling and freeze-drying unit for veterinary vaccines at its Biosciences Center Boxmeer in the Netherlands. The opening of the Central Filling and Freeze-drying Department was performed by her Royal Highness Princess Máxima of the Netherlands in the presence of His Excellency the Minister of Economic Affairs, Agriculture and Innovation, Maxime Verhagen, and other guests.
Mongolia - MNT300 Million for FMD
As the spread of FMD still continued and the disease outbreak risk is still high, the Cabinet has decided to allocate MNT300 million for the purchase of 600,000 dozes of vaccine from Russia and for injection costs.
Sanitary Equilibrium: The role of PCV2 vaccines
The most common problems are due to interference with maternal antibodies and coincidence of vaccination with a recirculation of PRRS: viremic animals.
The effect of supplementing dry feed with a nutritional gel additive at the time of vaccination on nursery pig behaviour
A nutritional gel supplementation reduces the negative impact of vaccination on piglet behaviour.
Dynamics and longevity of maternally-acquired antibodies to Taenia solium in piglets born to naturally infected sows
The observed variations in the level of maternally-acquired Abs amongst piglets will pose a major challenge to the implementation of vaccination programmes against T. solium cysticercosis.
Day one Mycoplasma hyopneumoniae vaccination now possible with RespiSure-ONE®
Pork producers in US can now vaccinate for mycoplasmal pneumonia at day one.
Intervet/Schering-Plough animal health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swine
Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and safe as separate use of these vaccines.
IDRI And Merial Enter Into Research Collaboration
Global animal health company Merial Ltd. and non-profit biotechnology organization the Infectious Disease Research Institute (IDRI) today announce they have agreed to cooperate regarding the research and development of certain vaccines for animals.
Biolex and Merial Broaden Collaboration
Biolex Therapeutics, Inc and Merial Ltd today announced that they have entered into a new, broad-ranging research and development collaboration to produce innovative veterinary vaccines.
First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union
The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo®.
Boehringer Ingelheim launches PCV2 vaccine in Russia
With the launch of Ingelvac CircoFLEX® by Boehringer Ingelheim on the Russian market, pig producers in Russia now have access to the world’s market leading vaccine against porcine Circovirus type 2 (PCV2).
Intervet/Schering-Plough Animal Health receives positive opinion in europe for simultaneous use of Porcilis® PRRS and Porcilis® M hyo vaccines in piglets
Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) concluded the referral procedure for PORCILIS® PRRS and for PORCILIS® M Hyo on simultaneous administration of these products in piglets
European Union - Commission clears acquisition of anial health assets of Pfizer by Eli Lilly&Co
The European Commission has granted clearance under the EU Merger Regulation to the acquisition of animal health assets of Pfizer by Eli Liily & Co, both of the USA.